Select Medical Holdings Corporation SEM is well-poised to grow on the back of strategic acquisitions and partnerships with large healthcare systems. Its diversified business and growing patient admissions bode well.
Select Medical — with a market cap of $3.8 billion — is a healthcare company with multiple long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. It has operations in 46 states and in the District of Columbia.
Courtesy of solid prospects, this Zacks Rank #3 (Hold) stock is worth holding on to at the moment.
The Zacks Consensus Estimate for Select Medical’s 2021 earnings is pegged at $3.05 per share, indicating a 61.4% year-over-year rise. The company beat earnings estimates in each of the last four quarters, the average surprise being 69.2%.
Select Medical Holdings Corporation price-eps-surprise | Select Medical Holdings Corporation Quote
The consensus estimate for 2021 revenuesstands at $6.2 billion, suggesting a 11.4% rise.
Along with the Zacks Rank #3, the company currently has a VGM Score of B. Our research shows that stocks with a VGM Score of A or B combined with a Zacks Rank #1 (Strong Buy) or 2 (Buy) or 3 offer the best investment opportunities. You can see the complete list of today’s Zacks #1 Rank stocks here.
Select Medical is well-positioned to benefit from rising demand for medical services owing to an aging population, which will drive growth across its business segments. Also, the rising incidence of diseases is resulting in an increase in the number of patient admissions. The company is focused on making strategic acquisitions to boost its business through inorganic growth. It is poised to capitalize on consolidation opportunities within each of its business segments, which operate in a highly fragmented market and selectively augment the company’s internal growth. Realizing efficiencies from its centralized operations and management is crucial to its businessgrowth.
Over the 2021-2023 forecast period, SEM’s long-term guidance for sales, adjusted EBITDA and earnings per common share were flat with the prior outlook. The company is targeting a revenue CAGR of 4-6%, adjusted EBITDA in the 7-8% band and EPS within 17-20%. Solid guidance instills investors’ confidence in the stock.
Select Medical teams up with large healthcare systems to provide post-acute care services. It offers operating expertise to these ventures through its experience in running critical illness recovery hospitals, rehabilitation hospitals and outpatient rehabilitation facilities. Alliances with other healthcare entities are helping the company augment its top line. The metric was up 14.1% year over year in the first nine months of 2021.
However, there are a few factors that are impeding the growth of the stock lately.
Its high debt burden in concerning. SEM’s net debt-to-capital is 55.9%, much higher than the industry’s average of 19.1%. At the third quarter-end, Select Medical had cash and cash equivalents of only $748 million, while long-term debt, net of current portion, amounted to $3.4 billion. This can affect its financial flexibility. Also, increasing costs are eating into its profits. Its total costs and expenses in the first nine months of 2021 were $4,142.3 million, up 11.3% from the year-ago period. Nevertheless, we believe that a systematic and strategic plan of action will drive its long-term growth.
Some better-ranked stocks in the medical space are Co-Diagnostics, Inc. CODX, HealthEquity, Inc. HQY and Harrow Health, Inc. HROW, each carrying a Zacks Rank #2.
Salt Lake City, UT-based Co-Diagnostics provides a wide range of testing services to customers. Its joint venture CoSara in India is likely to have boosted its addressable market size. Also, Co-Diagnostics’ Logix Smart™ ABC test received a green signal from the Mexican watchdogs. Deals like these will keep strengthening its client base around the world.
The molecular diagnostics company’s bottom line for 2021 has witnessed one upward estimate revision in the past 30 days and no movement in the opposite direction. During this time period, Co-Diagnostics’ earnings estimates have risen 17.9%. CODX beat earnings estimates thrice in the last four quarters and missed once, the average surprise being 35.6%.
Headquartered in Draper, UT, HealthEquity is engaged in a series of buyouts and collaborations over the past few months. The company, in April, entered into a definitive agreement with Fifth Third Bank, National Association to transition custodianship of Fifth Third’s Health Savings Accounts portfolio to HealthEquity.
HQY’s bottom line for current year has witnessed one upward estimate revision in the past 30 days and no movement in the opposite direction. HealthEquity beat earnings estimates in each of the past four quarters, the average surprise being 13.3%.
Based in San Diego, CA, Harrow Health is an ophthalmic-focused healthcare firm. Its recent acquisitions of ophthalmic surgical drug candidates from Sintetica and Wakamoto Pharmaceutical are major positives. Moves like these are likely to bolster Harrow Health’s commercial success in the U.S. and Canadian markets.
Harrow Health’s bottom line for 2021 is expected to soar 346.2% year over year. It has witnessed one upward estimate revision in the past 30 days and no movement in the opposite direction. HROW beat earnings estimates thrice in the past four quarters and missed once, the average surprise being 38%.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Select Medical Holdings Corporation (SEM) : Free Stock Analysis Report
HealthEquity, Inc. (HQY) : Free Stock Analysis Report
Harrow Health, Inc. (HROW) : Free Stock Analysis Report
CoDiagnostics, Inc. (CODX) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
As it turns out, during so-called Federal Reserve interest rate-hike cycles, which we seem set to enter as early as March, the U.S. stock market tends to perform strongly, not poorly.
As the threat of a Russian invasion of Ukraine remains on the radar, analysts and traders assess the ripples such an event would send through global financial markets.
Inflation is at 40-year highs. These stocks can help ease the pain.
Low rates and high inflation make cash tough to hold. Look here instead.
The automotive sector is in the midst of an enormous change. A combination of social and political forces are pushing the industry more and more toward adoption of electric vehicles (EVs) as a new standard – although the internal combustion engine is not likely to be fully phased out, EVs are certain to find a large niche. ‘Last mile’ delivery, and various fleet businesses are already finding that EVs can meet their needs efficiently. But the electric car market isn’t just about cars. They may g
Buy the dip, wrote J.P. Morgan’s strategists early this past week. Yes, the U.S. inflation rate just hit 7%, the highest since 1982, back when E.T. was phoning home and the rich kid on my street got a Commodore 64 computer—his old man worked for IBM. J.P. Morgan compares now with late 2018, when rate increases sparked a stock selloff, and the Fed later reversed course.
(Bloomberg) — The CES technology show in Las Vegas last week was an important milestone for Elon Musk’s Boring Co., which operates a network of underground tunnels to ferry passengers around the massive convention center in Tesla Inc. cars.Most Read from BloombergDirecTV to Drop One America News in Blow to Conservative ChannelCovid Pandemic May Shift to Endemic in 2022, Moderna Chair SaysShould I Be Wearing an N95 or KN95? Understanding the Evolving Advice on MasksCannabis Compounds Prevented C
Last year, shares of fintech giant PayPal Holdings (NASDAQ: PYPL) fell as investors weren't pleased with the company's decelerating revenue growth. The market is accustomed to PayPal delivering higher growth rates than that, which explains why some investors aren't too optimistic about the company right now. In 2020, PayPal's business experienced abnormal growth as customers shifted their habits at the onset of the pandemic.
Everyone loves fast-growing S&P 500 companies — they just don't want to pay up. Analysts are finding still-cheap growing companies.
You'll wait a few weeks or even months, but you get exactly what you want, and in this current market, you’re likely to save money, too.
The stock market rally is on the back foot, while the Nasdaq has lagged the S&P 500 for nearly a year. But Apple is holding up.
The company formally known as Square, is down about 31% since announcing its corporate entity name change to Block, on Dec. 1 of last year.
WASHINGTON (Reuters) -The largest satellite provider in the United States said late Friday it will drop One America News, a move that could financially cripple the rightwing TV network known for fueling conspiracy theories about the 2020 election. The announcement by DirecTV, which is 70% owned by AT&T, comes three months after a Reuters investigation revealed that OAN’s founder testified that AT&T inspired him to create the network. Court testimony also showed that OAN receives nearly all of its revenue from DirecTV.
(Bloomberg) — The tech stock-rout, as steep as it’s been, has still only pushed the Nasdaq Composite Index down about 8% from its November high, just shy of an official correction for a benchmark that’s more than doubled in less than two years.Most Read from BloombergCannabis Compounds Prevented Covid Infection in Laboratory StudyDirecTV to Drop One America News in Blow to Conservative ChannelCovid Pandemic May Shift to Endemic in 2022, Moderna Chair SaysFrequent Boosters Spur Warning on Immune
Our call of the day from Michael Loukas, principal & CEO of TrueMark Investments, offers up 'category killers' in tech such as AI, cybersecurity and deep learning.
The electric vehicle company has a production plan that shows just how speculative its nearly $70 billion valuation is.
Despite lagging the market in the past year, these two tech companies boast historical returns any company would be proud of.
If you're on the hunt for a few smart stocks that have the potential to maximize the earning potential of $200, then consider what Apple (NASDAQ: AAPL), Costco Wholesale (NASDAQ: COST), and Upstart Holdings (NASDAQ: UPST) have to offer. First, consider the company's fantastic growth from its services business. Apple's services include everything from sales in its App Store to its premium subscriptions (Apple One, Apple News+, AppleTV+ Apple Music, etc.), and business is booming right now.
(Bloomberg) — Most Read from BloombergCannabis Compounds Prevented Covid Infection in Laboratory StudyFrequent Boosters Spur Warning on Immune ResponseSupreme Court Blocks Biden’s Shot-or-Test Rule for WorkersSay Goodbye to Self-Isolating, WFH Mandates, Mass TestingDjokovic’s Australian Visa Canceled Again in Public InterestAmy Wu has left Lightspeed Venture Partners for crypto-exchange FTX, where she will lead a newly launched $2 billion venture capital fund. The fund, known as FTX Ventures, w
If you're looking to invest in artificial intelligence companies, these three are amazing growth ideas.